Status:

COMPLETED

Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France

Lead Sponsor:

AstraZeneca

Conditions:

Healthy

Eligibility:

All Genders

65+ years

Brief Summary

The purpose of this study is to assess in general population NSAID and gastroprotective agent utilization and compliance in elderly people.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • French people \> 65 years old, part of Kantar Health Access Santé panel

Exclusion

    Key Trial Info

    Start Date :

    October 1 2010

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    November 1 2010

    Estimated Enrollment :

    8186 Patients enrolled

    Trial Details

    Trial ID

    NCT01211652

    Start Date

    October 1 2010

    End Date

    November 1 2010

    Last Update

    January 29 2013

    Active Locations (3510)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 878 (3510 locations)

    1

    Research Site

    Abancourt, France

    2

    Research Site

    Ablain-Saint-Nazaire, France

    3

    Research Site

    Ablis, France

    4

    Research Site

    Ablon-sur-Seine, France

    Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in France | DecenTrialz